﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-10-28T08:40:39-04:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>232978890</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PEARL ASSOCIATES</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1036 MILLCREEK DR</AddressLine1Txt>
        <CityNm>FEASTERVILLE TREVOSE</CityNm>
        <StateAbbreviationCd>PA</StateAbbreviationCd>
        <ZIPCd>19053</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>475210479</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>CHERNOWITZ MEDICAL RESEARCH</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>FOUNDATION INC</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>CHER</BusinessNameControlTxt>
      <PhoneNum>8009018658</PhoneNum>
      <USAddress>
        <AddressLine1Txt>4161 XAVIER STREET</AddressLine1Txt>
        <CityNm>DENVER</CityNm>
        <StateAbbreviationCd>CO</StateAbbreviationCd>
        <ZIPCd>80212</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>RICHARD JACOBY</PersonNm>
      <PersonTitleTxt>TRUSTEE</PersonTitleTxt>
      <PhoneNum>2157400870</PhoneNum>
      <SignatureDt>2024-10-22</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>KRISTI SHARPE</PreparerPersonNm>
      <PTIN>P01317490</PTIN>
      <PhoneNum>2153223985</PhoneNum>
      <PreparationDt>2024-10-28</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990PF documentId="RetDoc12" referenceDocumentId="RetDoc10">
      <AddressChangeInd>X</AddressChangeInd>
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>8280846</FMVAssetsEOYAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AnalysisOfRevenueAndExpenses>
        <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
        <InterestOnSavRevAndExpnssAmt>1277</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>1277</InterestOnSavNetInvstIncmAmt>
        <DividendsRevAndExpnssAmt>190849</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>190849</DividendsNetInvstIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>-183726</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>2311077</GrossSalesPriceAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc7">53118</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>53118</OtherIncomeNetInvstIncmAmt>
        <TotalRevAndExpnssAmt>61518</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>245244</TotalNetInvstIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>125004</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>24001</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstAdjNetIncmAmt>56003</CompOfcrDirTrstAdjNetIncmAmt>
        <PensionEmplBnftRevAndExpnssAmt>9755</PensionEmplBnftRevAndExpnssAmt>
        <PensionEmplBnftNetInvstIncmAmt>2927</PensionEmplBnftNetInvstIncmAmt>
        <PensionEmplBnftAdjNetIncmAmt>6828</PensionEmplBnftAdjNetIncmAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="RetDoc8">5175</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>5175</OtherProfFeesNetInvstIncmAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc9">10634</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>10634</TaxesNetInvstIncmAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc5">37623</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>35804</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesAdjNetIncmAmt>1819</OtherExpensesAdjNetIncmAmt>
        <TotOprExpensesRevAndExpnssAmt>188191</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>78541</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesAdjNetIncmAmt>64650</TotOprExpensesAdjNetIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>0</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>704585</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>704585</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>892776</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>78541</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesAdjNetIncmAmt>64650</TotalExpensesAdjNetIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>704585</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>-831258</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>166703</NetInvestmentIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <USGovernmentObligationsBOYAmt>213095</USGovernmentObligationsBOYAmt>
        <USGovernmentObligationsEOYAmt referenceDocumentId="RetDoc4">116977</USGovernmentObligationsEOYAmt>
        <USGovtObligationsEOYFMVAmt>116977</USGovtObligationsEOYFMVAmt>
        <CorporateStockBOYAmt>6613617</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc3">6714143</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>6714143</CorporateStockEOYFMVAmt>
        <CorporateBondsBOYAmt>1437783</CorporateBondsBOYAmt>
        <CorporateBondsEOYAmt referenceDocumentId="RetDoc2">1449726</CorporateBondsEOYAmt>
        <CorporateBondsEOYFMVAmt>1449726</CorporateBondsEOYFMVAmt>
        <TotalAssetsBOYAmt>8264495</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>8280846</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>8280846</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
        <NoDonorRstrNetAssestsBOYAmt>8264495</NoDonorRstrNetAssestsBOYAmt>
        <NoDonorRstrNetAssestsEOYAmt>8280846</NoDonorRstrNetAssestsEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>8264495</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>8280846</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>8264495</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>8280846</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>8264495</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>-831258</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt referenceDocumentId="RetDoc6">847609</OtherIncreasesAmt>
        <SubtotalAmt>8280846</SubtotalAmt>
        <TotNetAstOrFundBalancesEOYAmt>8280846</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MIRATI THERAPEUTICS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-05-15</AcquiredDt>
          <SoldDt>2023-08-02</SoldDt>
          <GrossSalesPriceAmt>11876</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>19885</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8009</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8009</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GMO BENCHMARK FREE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-02-14</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>26201</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25800</CostOrOtherBasisAmt>
          <GainOrLossAmt>401</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>401</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AXONIC STRATEGIC INCOME</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-11-12</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>39493</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>44989</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5496</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5496</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>KRANESHARES TR BOSERA</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-08-31</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>2544</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3365</CostOrOtherBasisAmt>
          <GainOrLossAmt>-821</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-821</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>VANECK EFT VANECKGOLD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-03-03</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>62622</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>66460</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3838</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3838</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>QUANTERIX CORP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-08-28</AcquiredDt>
          <SoldDt>2023-10-16</SoldDt>
          <GrossSalesPriceAmt>19950</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>24909</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4959</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4959</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JP MORGAN STRATEGIC INCOME</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-02-14</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>14438</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>14400</CostOrOtherBasisAmt>
          <GainOrLossAmt>38</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>38</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK STRATEGIC INCOME</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-07-16</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>103365</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>111184</CostOrOtherBasisAmt>
          <GainOrLossAmt>-7819</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-7819</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>WISDOMTREE CHINA</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-08-31</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>334</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>377</CostOrOtherBasisAmt>
          <GainOrLossAmt>-43</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-43</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ACLARIS THERAPEUTICS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-06-09</AcquiredDt>
          <SoldDt>2023-03-29</SoldDt>
          <GrossSalesPriceAmt>4119</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>9010</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4891</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4891</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AB SELECT US LONG SHORT PORT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-02-14</SoldDt>
          <GrossSalesPriceAmt>23312</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>23855</CostOrOtherBasisAmt>
          <GainOrLossAmt>-543</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-543</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>COHEN AND STEERS LOW DURATION</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>225174</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>246193</CostOrOtherBasisAmt>
          <GainOrLossAmt>-21019</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-21019</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CONSUMER DISCRETIONARY</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-03-03</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>7253</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8704</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1451</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1451</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ALLOGENE THERAPEUTICS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-06-09</AcquiredDt>
          <SoldDt>2023-05-15</SoldDt>
          <GrossSalesPriceAmt>3355</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>12504</CostOrOtherBasisAmt>
          <GainOrLossAmt>-9149</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-9149</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ABBEY CAPITAL FUTURES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>17809</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18259</CostOrOtherBasisAmt>
          <GainOrLossAmt>-450</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-450</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GUGGENHEIM MACRO OPP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>120399</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>128526</CostOrOtherBasisAmt>
          <GainOrLossAmt>-8127</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-8127</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOLDMAN SACHS GQG PRT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-01-05</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>10698</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10854</CostOrOtherBasisAmt>
          <GainOrLossAmt>-156</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-156</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>APPLE INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-01-18</AcquiredDt>
          <SoldDt>2023-05-15</SoldDt>
          <GrossSalesPriceAmt>66003</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>68628</CostOrOtherBasisAmt>
          <GainOrLossAmt>-2625</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-2625</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ALLSPRING ABSOLUTE RETURN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-02-14</SoldDt>
          <GrossSalesPriceAmt>16455</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>17235</CostOrOtherBasisAmt>
          <GainOrLossAmt>-780</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-780</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>T ROWE PRICE US GOVT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>156887</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>193529</CostOrOtherBasisAmt>
          <GainOrLossAmt>-36642</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-36642</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INVESCO EXCH TRADED</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-01-27</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>67747</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>81713</CostOrOtherBasisAmt>
          <GainOrLossAmt>-13966</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-13966</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ALPURINA PHARMA</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-12-24</AcquiredDt>
          <SoldDt>2023-10-16</SoldDt>
          <GrossSalesPriceAmt>15300</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>40740</CostOrOtherBasisAmt>
          <GainOrLossAmt>-25440</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-25440</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ALPHASIMPLEX MANAGED</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-02-14</SoldDt>
          <GrossSalesPriceAmt>1542</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1530</CostOrOtherBasisAmt>
          <GainOrLossAmt>12</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>12</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ALPS CORECOM MGT</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-03-20</AcquiredDt>
          <SoldDt>2023-12-05</SoldDt>
          <GrossSalesPriceAmt>265000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>271021</CostOrOtherBasisAmt>
          <GainOrLossAmt>-6021</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-6021</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INVESCO EXCH TRADED SLFIDX</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-12-09</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>28421</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>29568</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1147</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1147</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>HOLOGIC INC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-08-23</AcquiredDt>
          <SoldDt>2023-08-02</SoldDt>
          <GrossSalesPriceAmt>15251</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>15467</CostOrOtherBasisAmt>
          <GainOrLossAmt>-216</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-216</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AQR MANAGED FUTURES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>10351</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>10480</CostOrOtherBasisAmt>
          <GainOrLossAmt>-129</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-129</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>AMERICAN CENTURY US SMALL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>3679</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>3652</CostOrOtherBasisAmt>
          <GainOrLossAmt>27</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>27</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INVESCO EXCH TRADED PRFZ</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-01-27</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>45962</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>46912</CostOrOtherBasisAmt>
          <GainOrLossAmt>-950</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-950</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INSULET CORP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-06-09</AcquiredDt>
          <SoldDt>2023-08-28</SoldDt>
          <GrossSalesPriceAmt>37272</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>56056</CostOrOtherBasisAmt>
          <GainOrLossAmt>-18784</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-18784</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CALAMOS MARKET NEUTRAL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>40253</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>36423</CostOrOtherBasisAmt>
          <GainOrLossAmt>3830</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3830</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CAPTIAL GROWTH</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>2235</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2223</CostOrOtherBasisAmt>
          <GainOrLossAmt>12</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>12</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INVESCO OPPENHEIMER INTL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <GrossSalesPriceAmt>136614</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>159130</CostOrOtherBasisAmt>
          <GainOrLossAmt>-22516</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-22516</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>MODERNA</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-08-17</AcquiredDt>
          <SoldDt>2023-04-13</SoldDt>
          <GrossSalesPriceAmt>16073</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6875</CostOrOtherBasisAmt>
          <GainOrLossAmt>9198</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>9198</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CHIRON CAPITAL ALLOCATION</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>23794</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>22453</CostOrOtherBasisAmt>
          <GainOrLossAmt>1341</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>1341</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>CAPITAL GROUP INTL FOCUS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>4650</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>4576</CostOrOtherBasisAmt>
          <GainOrLossAmt>74</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>74</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ISHARES TR MSCI ACWIEX</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-04-05</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>19682</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>21494</CostOrOtherBasisAmt>
          <GainOrLossAmt>-1812</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-1812</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>POLYPID LTD</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-12-21</AcquiredDt>
          <SoldDt>2023-05-15</SoldDt>
          <GrossSalesPriceAmt>365</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>11029</CostOrOtherBasisAmt>
          <GainOrLossAmt>-10664</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-10664</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FPA CRESENT FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>37417</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>33025</CostOrOtherBasisAmt>
          <GainOrLossAmt>4392</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4392</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FIRST TR EXCHANGE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>549</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>545</CostOrOtherBasisAmt>
          <GainOrLossAmt>4</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>KOPERNIK GLOBAL ALL CAP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-01-05</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>5820</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6760</CostOrOtherBasisAmt>
          <GainOrLossAmt>-940</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-940</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>PROTAGONIST THERAPEUTICS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-09-21</AcquiredDt>
          <SoldDt>2023-05-15</SoldDt>
          <GrossSalesPriceAmt>26020</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>23355</CostOrOtherBasisAmt>
          <GainOrLossAmt>2665</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2665</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>GOTHAM ABSOLUTE RETURN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>33910</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25654</CostOrOtherBasisAmt>
          <GainOrLossAmt>8256</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>8256</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FIRST TR EXCHANGE</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-12-29</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>14895</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>14860</CostOrOtherBasisAmt>
          <GainOrLossAmt>35</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>35</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>NUVEEN DIVIDEND GROWTH CLASS</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-12-08</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>40731</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>38192</CostOrOtherBasisAmt>
          <GainOrLossAmt>2539</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2539</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>TWIST BIOSCIENCE CORP</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2020-12-21</AcquiredDt>
          <SoldDt>2023-04-13</SoldDt>
          <GrossSalesPriceAmt>2780</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>29249</CostOrOtherBasisAmt>
          <GainOrLossAmt>-26469</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-26469</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JP MORGAN STRATEGIC</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>24427</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>24534</CostOrOtherBasisAmt>
          <GainOrLossAmt>-107</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-107</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>INDUSTRIAL SELECT SECTOR</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>2522</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2461</CostOrOtherBasisAmt>
          <GainOrLossAmt>61</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>61</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>OAKMARK INTL INVESTOR</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2018-03-15</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>2663</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2857</CostOrOtherBasisAmt>
          <GainOrLossAmt>-194</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-194</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ABBEY CAPITAL FUTURES</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-02-14</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>505</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>500</CostOrOtherBasisAmt>
          <GainOrLossAmt>5</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>5</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>LEGG MASON WESTERN ASSET</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-02-14</SoldDt>
          <GrossSalesPriceAmt>15514</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>18742</CostOrOtherBasisAmt>
          <GainOrLossAmt>-3228</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-3228</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ISHARES MSCI EMER MARKET</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>2475</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2473</CostOrOtherBasisAmt>
          <GainOrLossAmt>2</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>2</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SELECT SECTOR SPDR TR</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-01-27</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>42713</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>38909</CostOrOtherBasisAmt>
          <GainOrLossAmt>3804</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>3804</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>BLACKROCK EVENT DRIVEN</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-02-14</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>25669</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>25800</CostOrOtherBasisAmt>
          <GainOrLossAmt>-131</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-131</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>VIRTUS APLHASIMPLEX</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2019-08-13</AcquiredDt>
          <SoldDt>2023-10-23</SoldDt>
          <GrossSalesPriceAmt>5877</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>6123</CostOrOtherBasisAmt>
          <GainOrLossAmt>-246</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-246</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>ISHARES TR MSCI ACW</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2022-12-27</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>154775</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>144627</CostOrOtherBasisAmt>
          <GainOrLossAmt>10148</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>10148</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SPDR S&amp;P 500</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-12-09</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>112650</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>128547</CostOrOtherBasisAmt>
          <GainOrLossAmt>-15897</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-15897</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>FPA CRESENT FUND</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-02-14</AcquiredDt>
          <SoldDt>2023-10-13</SoldDt>
          <GrossSalesPriceAmt>2581</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>2500</CostOrOtherBasisAmt>
          <GainOrLossAmt>81</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>81</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>JP MORGAN STRATEGIC INCOME</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-03-15</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>38431</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>38856</CostOrOtherBasisAmt>
          <GainOrLossAmt>-425</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-425</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>KINETICS PARADIGM</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2023-04-10</AcquiredDt>
          <SoldDt>2023-04-21</SoldDt>
          <GrossSalesPriceAmt>7322</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>7918</CostOrOtherBasisAmt>
          <GainOrLossAmt>-596</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-596</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>SPDR SER TR SP OIL</PropertyDesc>
          <HowAcquiredCd>P</HowAcquiredCd>
          <AcquiredDt>2021-02-25</AcquiredDt>
          <SoldDt>2023-04-10</SoldDt>
          <GrossSalesPriceAmt>13299</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>8308</CostOrOtherBasisAmt>
          <GainOrLossAmt>4991</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>4991</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>-183726</CapitalGainNetIncomeAmt>
        <NetShortTermCapitalGainLossAmt>-4096</NetShortTermCapitalGainLossAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>2317</InvestmentIncomeExciseTaxAmt>
        <SubtotalAmt>2317</SubtotalAmt>
        <TaxBasedOnInvestmentIncomeAmt>2317</TaxBasedOnInvestmentIncomeAmt>
        <ExtsnRequestIncomeTaxPaidAmt>5200</ExtsnRequestIncomeTaxPaidAmt>
        <TotalPaymentsAndCreditsAmt>5200</TotalPaymentsAndCreditsAmt>
        <Form2220AttachedInd referenceDocumentId="RetDoc1">X</Form2220AttachedInd>
        <EsPenaltyAmt>126</EsPenaltyAmt>
        <OverpaymentAmt>2757</OverpaymentAmt>
        <AppliedToESTaxAmt>2757</AppliedToESTaxAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>false</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>false</MoreThan100SpentInd>
        <Form1120POLFiledInd>false</Form1120POLFiledInd>
        <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>false</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>true</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>true</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>NJ</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>CO</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>true</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>false</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>false</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>false</OwnControlledEntityInd>
        <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>true</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>WWW.CHERNOWITZ.ORG</WebsiteAddressTxt>
        <IndividualWithBooksNm>RICHARD JACOBY</IndividualWithBooksNm>
        <PhoneNum>8009018658</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>4161 XAVIER STREET</AddressLine1Txt>
          <CityNm>DENVER</CityNm>
          <StateAbbreviationCd>CO</StateAbbreviationCd>
          <ZIPCd>80210</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>false</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>false</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>false</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>false</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>false</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>false</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>false</PaymentToGovernmentOfficialInd>
        <UndistributedIncomePYInd>false</UndistributedIncomePYInd>
        <BusinessHoldingsInd>false</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>false</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>false</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>false</InfluenceLegislationInd>
        <InfluenceElectionInd>false</InfluenceElectionInd>
        <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>false</NoncharitablePurposeInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>RICHARD JACOBY</PersonNm>
          <USAddress>
            <AddressLine1Txt>4161 XAVIER STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80210</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>45000</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>BENJAMIN JACOBY</PersonNm>
          <USAddress>
            <AddressLine1Txt>3964 YATES STREET</AddressLine1Txt>
            <CityNm>DENVER</CityNm>
            <StateAbbreviationCd>CO</StateAbbreviationCd>
            <ZIPCd>80212</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>35004</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>JACK PLATT</PersonNm>
          <USAddress>
            <AddressLine1Txt>100 BREYER DRIVE UNIT 4D</AddressLine1Txt>
            <CityNm>ELKINS PARK</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19027</ZIPCd>
          </USAddress>
          <TitleTxt>TRUSTEE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>45000</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SumOfProgramRelatedInvstGrp>
        <Description1Txt>N/A</Description1Txt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>8315771</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>0</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>0</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>8315771</TotalFMVOfUnusedAssetsAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>8315771</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>124737</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>8191034</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>409552</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <MinimumInvestmentReturnAmt>409552</MinimumInvestmentReturnAmt>
        <TaxBasedOnInvestmentIncomeAmt>2317</TaxBasedOnInvestmentIncomeAmt>
        <TotalTaxAmt>2317</TotalTaxAmt>
        <DistributableBeforeAdjAmt>407235</DistributableBeforeAdjAmt>
        <DistributableBeforeDedAmt>407235</DistributableBeforeDedAmt>
        <DistributableAsAdjustedAmt>407235</DistributableAsAdjustedAmt>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>704585</ExpensesAndContributionsAmt>
        <QualifyingDistributionsAmt>704585</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <UndistributedIncomeGrp>
        <DistributableAsAdjustedAmt>407235</DistributableAsAdjustedAmt>
        <UndistributedIncomePYAmt>376204</UndistributedIncomePYAmt>
        <PriorYear1Yr>2018</PriorYear1Yr>
        <TotalForPriorYearsAmt>29552</TotalForPriorYearsAmt>
        <QualifyingDistributionsAmt>704585</QualifyingDistributionsAmt>
        <AppliedToYear1Amt>376204</AppliedToYear1Amt>
        <AppliedToPriorYearsAmt>29552</AppliedToPriorYearsAmt>
        <AppliedToCurrentYearAmt>298829</AppliedToCurrentYearAmt>
        <UndistributedIncomeCYAmt>108406</UndistributedIncomeCYAmt>
      </UndistributedIncomeGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>3451 WALNUT STREET</AddressLine1Txt>
            <AddressLine2Txt>5TH FLOOR</AddressLine2Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19104</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>501(C)(3)</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MEDICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>200000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF MIAMI</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>PO BOX 025388</AddressLine1Txt>
            <CityNm>MIAMI</CityNm>
            <StateAbbreviationCd>FL</StateAbbreviationCd>
            <ZIPCd>33102</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>501(C)(3)</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MEDICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>200585</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>UNIVERSITY OF ROCHESTER</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>910 GENESEE STREET SUITE</AddressLine1Txt>
            <CityNm>ROCHESTER</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>14611</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>501(C)(3)</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MEDICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>160000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <GrantOrContributionPdDurYrGrp>
          <RecipientBusinessName>
            <BusinessNameLine1Txt>MOSS REHABILITATION</BusinessNameLine1Txt>
          </RecipientBusinessName>
          <RecipientUSAddress>
            <AddressLine1Txt>5501 OLD YORK ROAD</AddressLine1Txt>
            <CityNm>PHILADELPHIA</CityNm>
            <StateAbbreviationCd>PA</StateAbbreviationCd>
            <ZIPCd>19141</ZIPCd>
          </RecipientUSAddress>
          <RecipientFoundationStatusTxt>501(C)(3)</RecipientFoundationStatusTxt>
          <GrantOrContributionPurposeTxt>MEDICAL RESEARCH</GrantOrContributionPurposeTxt>
          <Amt>144000</Amt>
        </GrantOrContributionPdDurYrGrp>
        <TotalGrantOrContriPdDurYrAmt>704585</TotalGrantOrContriPdDurYrAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>1277</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>190849</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <OtherInvestmentIncomeGrp>
          <RelatedOrExemptFunctionIncmAmt>53118</RelatedOrExemptFunctionIncmAmt>
        </OtherInvestmentIncomeGrp>
        <GainSalesAstOthThanInvntryGrp>
          <RelatedOrExemptFunctionIncmAmt>-183726</RelatedOrExemptFunctionIncmAmt>
        </GainSalesAstOthThanInvntryGrp>
        <SubtotalsIncmProducingActyGrp>
          <ExclusionAmt>192126</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>-130608</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>61518</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>false</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>false</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>false</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>false</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>false</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>false</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>false</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>false</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>false</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>false</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <InvestmentsCorpBondsSchedule documentId="RetDoc2">
      <InvestmentsCorporateBondsGrp>
        <BondNm>CORPORATE BONDS</BondNm>
        <EOYBookValueAmt>1449726</EOYBookValueAmt>
        <EOYFMVAmt>1449726</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
    </InvestmentsCorpBondsSchedule>
    <InvestmentsCorpStockSchedule documentId="RetDoc3">
      <InvestmentsCorporateStockGrp>
        <StockNm>CORPORATE STOCK</StockNm>
        <EOYBookValueAmt>6714143</EOYBookValueAmt>
        <EOYFMVAmt>6714143</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <InvestmentsGovtObligationsSch documentId="RetDoc4">
      <USGovtObligationsBookVlEOYAmt>116977</USGovtObligationsBookVlEOYAmt>
      <USGovtObligationsEOYFMVAmt>116977</USGovtObligationsEOYFMVAmt>
    </InvestmentsGovtObligationsSch>
    <OtherExpensesSchedule documentId="RetDoc5">
      <OtherExpensesScheduleGrp>
        <Desc>EXPENSES</Desc>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>WEBSITE</Desc>
        <RevenueAndExpensesPerBooksAmt>762</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>762</AdjustedNetIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>PAYROLL SERVICE FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>1004</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>301</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>703</AdjustedNetIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>ACCOUNT SERVICE FEES</Desc>
        <RevenueAndExpensesPerBooksAmt>35503</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>35503</NetInvestmentIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>MISCELLANEOUS</Desc>
        <RevenueAndExpensesPerBooksAmt>210</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>210</AdjustedNetIncomeAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>OFFICE</Desc>
        <RevenueAndExpensesPerBooksAmt>144</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>144</AdjustedNetIncomeAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc7">
      <OtherIncomeDetail>
        <Desc>PARTNERSHIP INCOME</Desc>
        <RevenueAndExpensesPerBooksAmt>53118</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>53118</NetInvestmentIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherIncreasesSchedule documentId="RetDoc6">
      <OtherIncreasesDetail>
        <Desc>UNREALIZED GAINS</Desc>
        <Amt>847609</Amt>
      </OtherIncreasesDetail>
    </OtherIncreasesSchedule>
    <OtherProfessionalFeesSchedule documentId="RetDoc8">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>PROFESSIONAL FEES</CategoryTxt>
        <Amt>5175</Amt>
        <NetInvestmentIncomeAmt>5175</NetInvestmentIncomeAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="RetDoc9">
      <TaxesDetail>
        <CategoryTxt>FOREIGN TAXES PAID</CategoryTxt>
        <Amt>2234</Amt>
        <NetInvestmentIncomeAmt>2234</NetInvestmentIncomeAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>EXCISE TAX</CategoryTxt>
        <Amt>8400</Amt>
        <NetInvestmentIncomeAmt>8400</NetInvestmentIncomeAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>